Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities. - Wikidata - awgldk - TriplyDB

Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities.

Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities.

http://www.wikidata.org/entity/Q33706037

about

Network medicine analysis of COPD multimorbidities Candidate genes for COPD: current evidence and research Oxidative stress and free radicals in COPD--implications and relevance for treatment A genome-wide analysis of the response to inhaled β2-agonists in chronic obstructive pulmonary disease.Variants of the ADRB2 Gene in COPD: Systematic Review and Meta-Analyses of Disease Risk and Treatment Response.Effect of Liuweibuqi capsules on the balance between MMP-9 and TIMP1 and viability of alveolar macrophages in COPD.Association of dopamine-related gene alleles, smoking behavior and decline in FEV1 in subjects with COPD: findings from the lung health study.Predicting treatable traits for long-acting bronchodilators in patients with stable COPD.

P2860

Q21146673-5C40E1D2-7D5C-47FB-81D5-7EA006C12260 Q26777324-9C0A7C42-0C57-40A2-9FED-525783E66779 Q26830076-1A714069-90AD-419D-BCC8-5421431C45C8 Q36844920-68344E96-995C-498B-8781-514BF1D9B25F Q39307440-84DDA596-32DB-460A-AF5D-3D3F5B1733EF Q41698292-040F6AF2-2466-48A7-8FBB-9130DA5A9EBF Q45940677-2796D430-16C0-4ED1-8BD1-DFB2C9CB9952 Q47107076-5CDD1CFB-DDDC-4211-9C1F-316D3D1506E9

P2860

Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities.

http://www.wikidata.org/entity/Q33706037

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities.

@ast

Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities.

@en

type

label

Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities.

@ast

Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities.

@en

prefLabel

Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities.

@ast

Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities.

@en

P1433

Q33706037-0975E622-5C2B-4374-A718-B5459B6AFE4E

P1476

Q33706037-E7C9038A-10EB-43E0-9E11-87F7407B3026

P2093

Q33706037-6CE816D6-D6E5-4D86-976A-13D220F2AFB1

P2860

Q33706037-0165DAB8-FCA3-4785-887A-1C0BBFFDA429

Q33706037-03DFC129-DCB3-4581-A4FB-1F3B5E315DCE

Q33706037-06B5A7CD-0698-48E5-A437-752E3910EB61

Q33706037-08157B94-914A-4E28-9BEA-E4355EEEF924

Q33706037-0853F3AF-12CC-4AF7-BEC2-AB17C2A89D27

Q33706037-090D4814-DE59-49C4-AB76-44C772F6CE19

Q33706037-092D7A69-2B97-4A0F-8F34-75CFB45D9901

Q33706037-0AD379E3-14CB-49AB-8978-C1030AB45A6A

Q33706037-0B78EB0B-595E-431E-BC2F-7971C0DFED44

Q33706037-149AE1C5-718B-4472-996F-7F146C5258A5

P304

Q33706037-0C006B74-3919-4A6E-81C8-1EF138BF477D

P31

Q33706037-B3B8A82A-0E92-4D20-AA55-CE1098F851BC

P356

Q33706037-BB52C2BD-264E-457B-9550-99F2F3CB3A7E

P433

Q33706037-8AA6DDDD-1248-4848-8862-21D8B8EBF4AA

P478

Q33706037-A68667E8-91C8-41F5-A1FE-032AF25A4016

P577

Q33706037-63223313-6F32-4B12-A91C-B9C9259ED3EE

P5875

Q33706037-3CD46CDB-C55D-4D94-9421-C94202EA7E0F

P698

Q33706037-C77139CB-4FFB-4DAD-8209-1E867FC945D9

P921

Q33706037-E1B64EA5-52A4-4C90-AE4B-028A4C51EFA6

P932

Q33706037-78364775-B1B6-49EA-9ED5-CD0A10D02A71

P356

P1433

Pharmacogenomics

P1476

Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities.

@en

P2093

Craig P Hersh

http://www.w3.org/2001/XMLSchema#string

P2860

Genome-wide and candidate gene association study of cigarette smoking behaviors

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

Molecular genetics of successful smoking cessation: convergent genome-wide association study results

Association of IL-1beta and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers

The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function

A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema

Polymorphisms in the IL13, IL13RA1, and IL4RA genes and rate of decline in lung function in smokers

Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1

Standardization of Spirometry, 1994 Update. American Thoracic Society

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

P304

237-247

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS.09.176

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41410985

http://www.w3.org/2001/XMLSchema#string

P698

20136362

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

P932

2832747

http://www.w3.org/2001/XMLSchema#string